The increase in MAS1 expression resulted in effective inhibition of cancer cell migration and had a potent anticancer effect, leading to significant suppression of tumorigenesis in xenograft models and reduced growth of patient tumor‐derived organoids. This evidence concerns the gene MAS1 and neoplasm.